Literature DB >> 11240902

Oestrus ovis (Diptera: Oestridae): effects of larval excretory/secretory products on nitric oxide production by murine RAW 264.7 macrophages.

G Tabouret1, I Vouldoukis, C Duranton, F Prevot, J P Bergeaud, P Dorchies, D Mazier, P Jacquiet.   

Abstract

Larvae of Oestrus ovis (Insecta: Diptera: Oestridae) are common parasites of nasal and sinus cavities of sheep and goats. Previous studies revealed that crude extracts of larvae modify NO synthesis by ovine monocyte derived macrophages. The aim of this study was to investigate the larval excretory/secretory products effects on nitric oxide production by murine tumour macrophages RAW 264.7. Stimulation of RAW macrophages by excretory/secretory products of the three instars larvae (25 microg/ml) significantly increased nitrite concentrations in culture supernatants compared to negative and positive Escherichia coli lipopolysaccharide control. This effect was time and dose dependent. Nitrite production in culture supernatants was due to induction of isoform NOS-2 because both NG monomethyl L-arginine (100 microM) and dexamethasone (20 microM) inhibited, by 60 and 50%, respectively, nitrite accumulation in culture supernatants. First steps of purification, by ion exchange chromatography, indicated that one protein of 29 kDa was able to induce NO synthesis by macrophages. Further studies are needed for a better characterization of these molecule and to investigate their immunogenicity for a vaccine approach.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11240902     DOI: 10.1046/j.1365-3024.2001.00355.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  1 in total

Review 1.  An Update on Cephenemyiosis in the European Roe Deer: Emergent Myiasis in Spain.

Authors:  Patrocinio Morrondo; Gerardo Pajares; María Sol Arias; Néstor Martínez-Calabuig; Susana Remesar; David García-Dios; Pablo Díaz; Ceferino Manuel López; Rosario Panadero; Pablo Díez-Baños
Journal:  Animals (Basel)       Date:  2021-11-26       Impact factor: 2.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.